CALP Insider Trading Activity and SEC Form 4 Filings
CALP insider trading summary
No open-market insider purchases or sales of Caliper Life Sciences Inc (CALP) have been reported on SEC Form 4 in the past 12 months.
Latest CALP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 1, 2011 | Stephen E Creager | Sr. VP and General Counsel | Sell | $52K (5,000 @ $10.47) |
| Oct 3, 2011 | Stephen E Creager | Sr. VP and General Counsel | Sell | $52K (5,000 @ $10.45) |
| Sep 1, 2011 | Stephen E Creager | Sr. VP and General Counsel | Sell | $38K (5,000 @ $7.52) |
| Aug 1, 2011 | Stephen E Creager | Sr. VP and General Counsel | Sell | $41K (5,000 @ $8.20) |
| Jul 1, 2011 | Peter F McAree | Sr.VP and CFO | Sell | $40K (5,000 @ $8.10) |
| Jul 1, 2011 | Stephen E Creager | Sr. VP and General Counsel | Sell | $41K (5,000 @ $8.11) |
| Jun 14, 2011 | David M Manyak | Exec VP, Drug Discovery Svcs | Sell | $143K (18,902 @ $7.54) |
| Jun 13, 2011 | David M Manyak | Exec VP, Drug Discovery Svcs | Sell | $8K (1,098 @ $7.56) |
| Jun 9, 2011 | David M Manyak | Exec VP, Drug Discovery Svcs | Sell | $75K (10,000 @ $7.48) |
| Jun 8, 2011 | David M Manyak | Exec VP, Drug Discovery Svcs | Sell | $108K (15,000 @ $7.18) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.